Each year, Alberta Health Services (the province wide, fully-integrated health system in Alberta) recognizes exceptional accomplishments by teams across the province through the President’s Excellence Awards.  Alberta’s Fracture Liaison Service […]

Prepared and reviewed by members of the Scientific Advisory Council of Osteoporosis Canada • Dr. Rick Adachi, Rheumatologist, McMaster University • Dr. Robert Josse, Endocrinologist, University of Toronto • Dr. […]

A development grant to improve osteoporosis care for fragility fracture patients has been awarded to British Columbia’s Fraser Health Authority. Funding for “Breaking The Cycle Of Recurrent Fracture: Scaling Up […]

If you buy drugs online, you may be putting your health at serious risk. This is especially true if you order prescription drugs without being examined in person by a […]

Denosumab A human monoclonal antibody that prevents RANKL-RANK interaction Denosumab (Bone Metabolism Regulator) Denosumab is a new class of osteoporosis treatment called a human monoclonal antibody that prevents RANKL-RANK interaction […]

Osteoporosis Canada is saddened to announce the passing of Dr. Timothy M. Murray, founding member of Osteoporosis Canada. Dr. Murray was the Emeritus Professor of Medicine at the University of […]

Awards The Osteoporosis Canada Tim Murray Short-Term Training Awards These awards provide individuals with the opportunity to learn more about osteoporosis, advance existing research skills in osteoporosis and/or present their […]

Facts & Stats Learn more about osteoporosis and related fractures Osteoporosis is a disease characterized by low bone mass and deterioration of bone tissue which can lead to increased risk […]

After rigorous peer review, the Michael Smith Foundation for Health Research (MSFHR) recently awarded the Fraser Health Authority team in British Columbia (BC), a three-year project team grant worth $500,000. […]